These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9742519)

  • 21. Overexpression of CD44v8-10 in Colon Polyps-A Possible Key to Early Diagnosis.
    Dastych M; Hubatka F; Turanek-Knotigova P; Masek J; Kroupa R; Raška M; Turanek J; Prochazka L
    Pathol Oncol Res; 2021; 27():614281. PubMed ID: 34257584
    [No Abstract]   [Full Text] [Related]  

  • 22. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
    Huang X; Sheng Y; Guan M
    Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development.
    Boman BM; Viswanathan V; Facey COB; Fields JZ; Stave JW
    Cancer Biol Ther; 2023 Dec; 24(1):2195363. PubMed ID: 37005380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer.
    Yorishima T; Nagai N; Ohama K
    Hiroshima J Med Sci; 1997 Mar; 46(1):21-9. PubMed ID: 9114564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of carbohydrate antigens to endothelial E-selectin binding in cancer cells].
    Chung YS; Yamada N; Sawada T; Takatsuka S; Sowa M
    Nihon Rinsho; 1995 Jul; 53(7):1747-52. PubMed ID: 7543165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44 variant, but not standard CD44 isoforms, mediate disassembly of endothelial VE-cadherin junction on metastatic melanoma cells.
    Zhang P; Fu C; Bai H; Song E; Dong C; Song Y
    FEBS Lett; 2014 Dec; 588(24):4573-82. PubMed ID: 25447529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.
    Li H; Hamou MF; de Tribolet N; Jaufeerally R; Hofmann M; Diserens AC; Van Meir EG
    Cancer Res; 1993 Nov; 53(22):5345-9. PubMed ID: 7693337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
    Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
    Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic biomarkers for metastatic colorectal cancer].
    Neumann JH
    Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases.
    Pereira PA; Rubenthiran U; Kaneko M; Jothy S; Smith AJ
    Anticancer Res; 2001; 21(4A):2713-7. PubMed ID: 11724345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
    Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
    Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of CD44 isoforms--a new histopathologic parameter in colorectal carcinoma?].
    Finke LH; Zörb C; Haensch W; Schlag PM; Terpe HJ
    Zentralbl Chir; 1996; 121(6):450-4. PubMed ID: 8767329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer.
    Miyagawa S; Soeda J; Takagi S; Miwa S; Ichikawa E; Noike T
    Hum Pathol; 2004 Nov; 35(11):1392-6. PubMed ID: 15668897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.